Danish-Norwegian study on adverse reactions after AstraZeneca vaccination is now published
In a Danish-Norwegian collaboration, researchers have shown a slightly increased rate of rare but serious types of cerebral blood clots as well as a generally increased rate of venous blood clots following vaccination with the AstraZeneca vaccine
2021-05-06
(Press-News.org) The new Danish-Norwegian study is the first study to document possible adverse events in relation to the COVID-19 vaccine Vaxzevria? from AstraZeneca, in which all vaccine recipients have been followed systematically, as opposed to previous studies, which have relied primarily on reported adverse reactions.
The new study was a cooperation between Danish and Norwegian research institutions.
- In this study, we were able to identify all hospital contacts among vaccinated persons by utilising the unique Danish and Norwegian health registers. This ensures that we get a comprehensive of the rate of adverse reactions. Previous studies have been dependent on spontaneous reporting of adverse events in individual patients, which carries a risk of under-reporting, says Anton Pottegård, who is a professor at the University of Southern Denmark and co-author of the study.
Study results have been continuously disseminated to Danish, Norwegian and international authorities and have already been accounted for in the assessments that have been made. Therefore, it is not expected that the publication of the study results will prompt new assessments by regulators.
The researchers behind the study stress that their findings do not conflict with the European Medicines Agency's (EMA) assessment that the vaccine is generally safe. The effects of the vaccine should be seen in the light of the benefits of using the vaccine, which protects against a potentially fatal infection. Depending on how severely affected the individual countries are by the epidemic, the benefits will therefore in many situations outweigh the risks of using the vaccine.
- The balancing of effects and risks of the vaccine depends on many factors. In many countries, for example those where there are no other vaccines available, where the elderly are not fully vaccinated or where there is a large spread of infection, the benefits of the vaccine will outweigh the risk, both at a societal level and for the individual vaccine recipient, says Anton Pottegård.
Systematic study of 280,000 vaccinated people aged 18-65
The study is based on data from the reputable Danish and Norwegian health registries, which allowed for systematic follow-up of all 280,000 vaccinated people aged 18-65 who have received Vaxzevria? in Norway and Denmark. The recipients of the vaccine were followed for 28 days after vaccination regarding hospital contacts in relation to a number of conditions and disorders that could represent adverse events. The incidence of these conditions and disorders was compared with the incidence in the background population.
The study is generally reassuring as researchers have not found an increased incidence for most of the studied adverse events. However, they identified an increased incidence of blood clots in the veins (venous blood clots), including a slightly increased incidence of blood clots in the veins of the brain, corresponding to one additional such clot per 40,000 vaccine recipients.
These rare blood clots in combination with low platelet counts are referred to as the VITT syndrome. The occurrence of VITT after receiving the AstraZeneca vaccine has led to the removal of the vaccine from the Danish and Norwegian vaccination programmes against COVID-19.
The absolute risk to the individual vaccine recipient is still considered to be low.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2021-05-06
Some clinicians are concerned that post-traumatic stress disorder (PTSD) diagnosis has risen throughout Western society since the late 1980s. Is this correct? And if so, has the true incidence of PTSD really spiralled out of control, or has it simply become overdiagnosed?
Experts debate the issue in The BMJ this week.
PTSD is a serious and uncommon condition resulting from severe trauma, but it has unhelpfully become an umbrella term incorporating other disorders and normal reactions to stress, argue John Tully at the University of Nottingham and Dinesh Bhugra at King's College London's Institute for Psychiatry, Psychology & Neuroscience (IoPPN).
Estimates of lifetime population prevalence are now about 7% in the US (26 million cases) and 5% in other high income countries. ...
2021-05-06
Admission to an intensive care unit (ICU) is associated with a small increased risk of future suicide or self-harm after discharge compared with non-ICU hospital admissions, finds a study published in The BMJ today.
The findings are particularly relevant during the covid-19 pandemic, as the number of ICU admissions around the world reach all-time highs.
The findings show that survivors of critical illness who later died by suicide or had self-harm events tended to be younger with a history of psychiatric illness, and had received invasive life support.
The researchers stress that the overall risk is still very low, but say knowledge of these factors "might allow for earlier intervention to potentially reduce this important public health problem."
Survival after ...
2021-05-06
Israel is the first country to report national data on the Pfizer-BioNTech vaccine, with observational analysis showing that two doses provide more than 95% protection against COVID-19 infection, hospitalisation, and death, including among the elderly, at a time when the B.1.1.7 variant was the dominant strain.
A single dose of the vaccine was associated with 58% protection against infection, 76% against hospitalisation, and 77% against death, emphasising the importance of fully vaccinating adults.
Challenges to controlling the pandemic remain, including uncertainty about ...
2021-05-06
R21/Matrix-M becomes the second malaria vaccine candidate ever to start a phase III licensure trial
This builds on the recent finding of high level efficacy of this vaccine in a phase IIb trial in children in Burkina Faso, published today in The Lancet
The first phase III trial doses were administered by the team at the Malaria Research and Training Centre, Bamako, Mali, one of five trial sites across West and East Africa
The malaria vaccine was designed at the Jenner Institute, University of Oxford, who have partnered with the Serum Institute of India for commercial development
The annual death toll from ...
2021-05-06
A new mutation found in a gene associated with an increased risk of atrial fibrillation poses a significantly increased risk for heart failure in Black people.
The discovery, made by researchers at the University of Illinois Chicago, could change current guidelines that recommend against genetic testing in people with atrial fibrillations, also known as AFib.
"We found that this new variant confers a significantly increased risk in African Americans, and this mutation has a 50% chance of being passed on to offspring," said Dr. Dawood Darbar, UIC professor of medicine and pharmacology at the College of Medicine. "Since it increases risk for heart failure, it would be wise to test people with atrial fibrillation to see if ...
2021-05-06
According to a new study published in the journal Research in Social and Administrative Pharmacy, hospitals that participate in the 340B Drug Pricing Program provide more medication access services -- which are services that help remove barriers to accessing necessary medications -- than comparably sized non-340B hospitals.
The University of Illinois Chicago researchers who conducted the study, which included a survey of available services sent to a nationally representative sample of hospitals across the U.S., suggest that 340B participating hospitals may be better positioned to create and administer programs that support patients who are uninsured ...
2021-05-05
Older people with kidney disease have a higher risk of dementia, and the risk increases with the rate and stage of kidney function decline. That is according to a large observational study by researchers at Karolinska Institutet in Sweden, published in the journal Neurology. The findings stress the significance of screening and monitoring for dementia in persons with kidney disease, the researchers say.
"Our study underscores the importance of low kidney function as a possible under-recognized risk factor for dementia," says co-author Juan Jesus Carrero, professor at the Department ...
2021-05-05
With increased media attention and political campaigns focusing on the gender pay gap, the fact that women -- on average -- are paid less than men, has become an important public discussion. While much of the focus has been on the corporate sector, a new study that looked at executive compensation at nonprofit organizations found that women earn 8.9% less than men with the gap becoming greater when there is room for salary negotiations.
The study co-authored by Curtis Hall, PhD, an associate professor in Drexel University's LeBow College of Business; Andrew R. Finley, assistant professor at the Robert Day School of Economics and Finance at Claremont McKenna College; and LeBow College of Business doctoral student Amanda R. Marino, analyzed data from IRS ...
2021-05-05
A multidisciplinary team of researchers from INRAP, CNRS, the universities of Ottawa, Rennes 2, Toulouse III Paul Sabatier and the Max Planck Institute has recognised the soldiers of the last battles of the siege of Rennes in 1491. These are the only witnesses of the forces involved in the conflict between the armies of Duchess Anne of Brittany and the King of France. This research and its methodology are currently the subject of two articles in the PLOS ONE review.
The excavation of the Jacobins convent in Rennes
From 2011 to 2013, a team from INRAP excavated the convent of the Jacobins, site of the future congress centre in Rennes Métropole, giving rise to numerous scientific ...
2021-05-05
New Haven, Conn. -- A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits of drug research are not being shared equitably among populations that participate in testing.
The study, published May 5 in JAMA Network Open, covers 34 novel drugs sponsored by large pharmaceutical companies that the U.S. Food and Drug Administration (FDA) approved between 2012 and 2014. Approvals were made on the basis of a total of 898 trials that were held in the United States and 70 other countries worldwide.
By analyzing the 563 trials for which location data was available, the researchers found that, five years after approval in the United States, only 15% of the drugs ...
LAST 30 PRESS RELEASES:
[Press-News.org] Danish-Norwegian study on adverse reactions after AstraZeneca vaccination is now published
In a Danish-Norwegian collaboration, researchers have shown a slightly increased rate of rare but serious types of cerebral blood clots as well as a generally increased rate of venous blood clots following vaccination with the AstraZeneca vaccine
